Chairman of the Board, President and CEO
Dr. Mjalli is an internationally recognized entrepreneur in the business of drug discovery and development of new medicines in the pharmaceutical and biotechnology industry. Dr. Mjalli is the founder of TransTech Pharma, LLC and High Point Pharmaceuticals, both of which are drug discovery development and commercialization companies, as well as High Point Clinical Trials Center (HPCTC), Inc, a clinical trials research and development center that conducts human clinical trials and PharmaCore, Inc, a drug manufacturing company. Dr. Mjalli served as Chairman and CEO of TransTech Pharma from December 1998 to April 2014. He currently serves as CEO of High Point Clinical Trials Center, Chairman of PharmaCore and director of both TransTech Pharma and High Point Pharmaceuticals. Dr. Mjalli obtained his PhD in Medicinal Chemistry in 1989 from the University of Exeter, UK. His postdoctoral work was carriedout at the University of Rochester. Dr. Mjalli has held various positions of increasing responsibility in research and senior management at several pharmaceutical and biotechnology companies including Merck & Co, Inc and Ontogen Corporation. He is the author of more than 40 scientific papers, four book chapters and an inventor on more than 700 patents and patent applications. Dr. Mjalli served on the Board of Directors of Siga Technoloies, the North Carolina Biotechnology Center, Guilford Technical Community College (GTCC), and the High Point Economic Development Corporation. Currently, Dr. Mjalli serves on the High Point University Board, the Foundation Board of GTCC, High Point Chamber of Commerce and is a member of the American Chemical Society. Dr. Mjalli has raised hundreds of millions of dollars for his companies listed above. He has also structured, negotiated and concluded an excess of a dozen multibillion-dollar deals with major global pharmaceutical companies.

Principal Investigator
Dr. Margarita Nuñez received her medical degree from New York Medical College and did her residency in Internal medicine at the University of South Florida College of Medicine, where she taught for three years as an Assistant Professor of Internal Medicine and Geriatrics. She is a fellowship-trained geriatrician and is Board Certified in Geriatric medicine. After leaving the University of South Florida and before entering her work in clinical trials she practiced internal medicine for an additional three years.Dr. Nuñez is an experienced Principal Investigator with over 16 years of clinical trial experience. She has served as Principal Investigator in over 350 trials in both late and early phase. For 15 years she served as Medical Director and Principal Investigator for a late phase site in the State of Florida.

Clinical Trial Manager
Antonio Guzmán graduated with a medical degree from ” Universidad Nuestra Señora de La Paz” school of medicine. Antonio has a strong background and understanding of medical aspects of clinical trials as well as experience as a coordinator in overseeing a number of Phase One clinical trials. His areas of expertise include overall study management including study conduct, subject safety, data collection and data entry supervision, staff training, quality assurance, screening and recruitment.

Senior Director, Screening and Recruitment
Issis Kelly- Pumarol Graduated from “Universidad Iberoamericana” School of medicine, Santo Domingo, Dominican Republic. Has dedicated most of her career to Clinical Research, from early drug development to post market research. With more than 11 years of experience, areas of expertise includes patient recruitment, screening, conduct of clinical trials and data collection.